HTR7 and neurodegenerative disease: Furthermore, recent preclinical findings suggest several possibilities in which 5-HT7 modulation can contribute to novel therapeutic targets for the treatment of several neuropsychiatric disorders, such as neurodevelopmental disorder, neurodegenerative diseases and metabolic complication associated with antipsychotics, through modulating intracellular signalling [5,42,44,45].